| Electrophysiological diagnosis of Guillain–Barré syndrome subtype: could a single study suffice? YA Rajabally, MC Durand, J Mitchell, D Orlikowski, G Nicolas Journal of Neurology, Neurosurgery & Psychiatry 86 (1), 115-119, 2015 | 218 | 2015 |
| A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics MW O’Reilly, CSJ Westgate, C Hornby, H Botfield, AE Taylor, K Markey, ... JCI insight 4 (6), 2019 | 124 | 2019 |
| Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial SP Mollan, JL Mitchell, RS Ottridge, M Aguiar, A Yiangou, Z Alimajstorovic, ... JAMA neurology 78 (6), 678-686, 2021 | 110 | 2021 |
| A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus HF Botfield, MS Uldall, CSJ Westgate, JL Mitchell, SM Hagen, ... Science translational medicine 9 (404), eaan0972, 2017 | 110 | 2017 |
| Topiramate is more effective than acetazolamide at lowering intracranial pressure WJ Scotton, HF Botfield, CSJ Westgate, JL Mitchell, A Yiangou, MS Uldall, ... Cephalalgia 39 (2), 209-218, 2019 | 78 | 2019 |
| Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic … R Ottridge, SP Mollan, H Botfield, E Frew, NJ Ives, T Matthews, J Mitchell, ... BMJ open 7 (9), e017426, 2017 | 78 | 2017 |
| Using optical coherence tomography as a surrogate of measurements of intracranial pressure in idiopathic intracranial hypertension V Vijay, SP Mollan, JL Mitchell, E Bilton, Z Alimajstorovic, KA Markey, ... JAMA ophthalmology 138 (12), 1264-1271, 2020 | 72 | 2020 |
| Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: minimal gain, is it worth the pain? A Yiangou, J Mitchell, KA Markey, W Scotton, P Nightingale, H Botfield, ... Cephalalgia 39 (2), 245-253, 2019 | 71 | 2019 |
| 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial K Markey, J Mitchell, H Botfield, RS Ottridge, T Matthews, A Krishnan, ... Brain Communications 2 (1), fcz050, 2020 | 66 | 2020 |
| Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning C Hornby, H Botfield, MW O’Reilly, C Westgate, J Mitchell, SP Mollan, ... Neuro-ophthalmology 42 (2), 99-104, 2018 | 59 | 2018 |
| Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension CSJ Westgate, HF Botfield, Z Alimajstorovic, A Yiangou, M Walsh, G Smith, ... JCI insight 6 (10), 2021 | 56 | 2021 |
| 11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension RS Hardy, H Botfield, K Markey, JL Mitchell, Z Alimajstorovic, ... The Journal of Clinical Endocrinology & Metabolism 106 (1), 174-187, 2021 | 54 | 2021 |
| Evaluation and management of adult idiopathic intracranial hypertension SP Mollan, C Hornby, J Mitchell, AJ Sinclair Practical neurology 18 (6), 485-488, 2018 | 53 | 2018 |
| The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial JL Mitchell, HS Lyons, JK Walker, A Yiangou, O Grech, Z Alimajstorovic, ... Brain 146 (5), 1821-1830, 2023 | 52 | 2023 |
| Hypokalaemia in ibuprofen and codeine phosphate abuse BT Dyer, JL Martin, JL Mitchell, NC Sauven, B Gazzard International Journal of Clinical Practice 58 (11), 1061-1062, 2004 | 50 | 2004 |
| What do transgender patients teach us about idiopathic intracranial hypertension? C Hornby, SP Mollan, J Mitchell, KA Markey, A Yangou, BLC Wright, ... Neuro-Ophthalmology 41 (6), 326-329, 2017 | 46 | 2017 |
| Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension SP Mollan, BR Wakerley, Z Alimajstorovic, J Mitchell, R Ottridge, ... The journal of headache and pain 22, 1-9, 2021 | 44 | 2021 |
| Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH: DT: clinical … KA Markey, R Ottridge, JL Mitchell, C Rick, R Woolley, N Ives, ... JMIR research protocols 6 (9), e7806, 2017 | 44 | 2017 |
| Erenumab for headaches in idiopathic intracranial hypertension: a prospective open‐label evaluation A Yiangou, JL Mitchell, C Fisher, J Edwards, V Vijay, Z Alimajstorovic, ... Headache: The Journal of Head and Face Pain 61 (1), 157-169, 2021 | 43 | 2021 |
| Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID DA Holdsworth, R Chamley, R Barker-Davies, O O’Sullivan, P Ladlow, ... PLoS One 17 (6), e0267392, 2022 | 41 | 2022 |
